-
Product Name
CTNS antibody
- Documents
-
Description
CTNS Rabbit Polyclonal antibody. Positive IHC detected in human pancreas cancer. Positive WB detected in HEK-293 cells, HeLa cells, HepG2 cells. Observed molecular weight by Western-blot: 45kd
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
human, mouse, rat; other species not tested.
-
Alternative names
CTNS antibody; CTNS LSB antibody; Cystinosin antibody; cystinosis antibody; nephropathic antibody; PQLC4 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of CTNS recombinant protein (Accession Number: XM_005256485). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:200-1:2000
IHC: 1:20-1:200
-
Validations
HEK-293 cells were subjected to SDS PAGE followed by western blot with Catalog No:109727(CTNS antibody) at dilution of 1:500
Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:109727(CTNS antibody) at dilution of 1:100 (under 10x lens)
-
Background
The CTNS or cystinosin is a lysosomal membrane protein which comprises with seven transmembrane domains, a 128 amino acid N-terminal region bearing seven N-glycosylation sites and a cytosolic C-terminal GYDQL sorting motif. It functions as a H+-driven cystine transporter responsible for cystine export from lysosomes. The mutation of CTNS gene cause an inherited disorder, cystinosis, characterized by defective lysosomal efflux of cystine. This antibody was raised against the N-terminal region of human cystinosin. Two isoforms of CTNS exist due to alternative splicing events and both of them can be detected through this antibody.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"